Impact of Social Determinants of Health on Outcomes Following Resection for Hepatocellular Carcinoma

被引:3
|
作者
Moten, Ambria S. [1 ]
Dickson, Paxton, V [1 ]
Deneve, Jeremiah L. [1 ]
Shibata, David [1 ,2 ]
Stanfill, Ansley G. [3 ]
Glazer, Evan S. [1 ,2 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA
[2] Univ Tennessee, Ctr Hlth Sci, Coll Med, Ctr Canc Res, Memphis, TN 38163 USA
[3] Univ Tennessee, Ctr Hlth Sci, Coll Nursing, Dept Acute & Tertiary Care, Memphis, TN 38163 USA
关键词
LIVER-TRANSPLANTATION; HEPATIC RESECTION; SURVIVAL; READMISSION; RACE; DISPARITIES;
D O I
10.1245/s10434-022-12735-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background We sought to determine the impact of social determinants of health (SDoH) on outcomes of patients undergoing resection for hepatocellular carcinoma (HCC). Patients and Methods Patients with HCC in the National Cancer Database who underwent resection from 2009 to 2018 were identified. SDoH associated with length of stay (LOS), 30-day readmission, and 30-day mortality were analyzed using regression analyses adjusted for confounding variables. Results Among 9235 patients, the median age (range) was 65.0 (18-90) years, 72.1% were male, and 57.9% were White. A total of 3% were uninsured, 11.1% had Medicaid, 21% resided in regions with a median household income within the lowest quartile of the US population, and 27.0% resided in regions within the lowest quartile of education level. The odds for having longer LOS were lower among patients with the highest regional education level compared with those with the lowest level [odds ratio (OR) 0.86, 95% confidence interval (CI) 0.77-0.97]. The risk of readmission was lower among patients with Medicare (OR 0.52; 95% CI 0.33-0.81), Medicaid (OR 0.52; 95% CI 0.31-0.87), or private insurance (OR 0.56; 95% CI 0.35-0.88) compared with uninsured patients. Thirty-day overall mortality was less likely among patients with Medicare (OR 0.45; 95% CI 0.27-0.75), Medicaid (OR 0.53; 95% CI 0.30-0.93), or private insurance (OR 0.40; 95% CI 0.24-0.66), and among patients with high regional income (OR 0.58; 95% CI 0.44-0.77). Conclusions Adjusted regression analyses identified SDoH that were associated with HCC outcomes. Increased awareness of how SDoH relate to outcomes may inform strategies that attempt to account for these associations and improve patient outcomes.
引用
收藏
页码:738 / 747
页数:10
相关论文
共 50 条
  • [31] Outcomes of Liver Resection for Hepatocellular Carcinoma in Octogenarians
    Wylie, Neil
    Sanyal, Sudip
    Hidalgo, Ernest
    Toogood, Giles
    Lodge, Peter
    BRITISH JOURNAL OF SURGERY, 2018, 105 : 48 - 48
  • [32] Outcomes of Liver Resection for Hepatocellular Carcinoma Patients
    Kumar, A.
    El-Gazzaz, G.
    Aucejo, F.
    Abdel-Wahab, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S190 - S191
  • [33] Outcomes of liver resection for hepatocellular carcinoma in octogenarians
    Sanyal, Sudip
    Kron, Philipp
    Wylie, Neil
    Hildalgo, Ernest
    Toogood, Giles J.
    Lodge, Peter
    HPB, 2020, 22 (09) : 1324 - 1329
  • [34] The effect of social determinants of health on utilization of surgical treatment for hepatocellular carcinoma patients
    Murthy, Shilpa S.
    Ortiz, Angel
    DuBois, Tesla
    Sorice, Kristen A.
    Nguyen, Minhhuyen
    Castellanos, Jason A.
    Pinheiro, Paulo
    Gonzalez, Evelyn T.
    Lynch, Shannon M.
    AMERICAN JOURNAL OF SURGERY, 2023, 225 (04): : 715 - 723
  • [35] Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma
    Singal, A. K.
    Freeman, D. H., Jr.
    Anand, B. S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (07) : 851 - 858
  • [36] Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma
    Sposito, C.
    Battiston, C.
    Facciorusso, A.
    Mazzola, M.
    Muscara, C.
    Scotti, M.
    Romito, R.
    Mariani, L.
    Mazzaferro, V.
    BRITISH JOURNAL OF SURGERY, 2016, 103 (07) : 871 - 880
  • [37] Health outcomes and social determinants
    Ganczak, M.
    Miazgowski, T.
    Kozybska, M.
    Kotwas, A.
    Korzen, M.
    Rudnicki, B.
    Nogal, T.
    Kopec, J.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2019, 29 : 327 - 327
  • [38] Outcomes Following Transplantation for Hepatocellular Carcinoma
    Tabrizian, P.
    Nakazawa, K.
    Prigoff, J.
    Schwartz, M.
    Florman, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 438 - 439
  • [39] The impact of social determinants of health on international migrants' health outcomes: a bibliometric analysis
    Sweileh, Waleed
    INTERNATIONAL JOURNAL OF MIGRATION HEALTH AND SOCIAL CARE, 2024, 20 (04) : 634 - 656
  • [40] Social determinants of hepatocellular carcinoma in Louisiana.
    Danos, Denise M.
    Ferguson, Tekeda F.
    Simonsen, Neal
    Leonardi, Claudia
    Yu, Qingzhao
    Wu, Xiao-Cheng
    Scribner, Richard
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 77 - 78